I have reviewed the provided documents and will now outline the research impact of the study titled "Accuracy of Predicting the Genetic Risk of Disease Using a Genome-Wide Approach" based on the Top 10 Dimensions of Research Impact. The research impact dimensions below are derived from the provided study (file: 2.pdf) and described according to the framework defined in the Knowledge - Potential RI by Dimensions document (file: Knowledge - Potential RI by Dimensions.txt).

1. Domains of Research Impact (RI)
Excerpts: The research provides critical insights into genome-wide methods for predicting the genetic risk of diseases. The formula derived by the authors has applications in various fields including human health and medical research. Specifically, it impacts genomic studies related to complex diseases like Type II Diabetes and Crohnâ€™s disease by offering improved accuracy in genetic risk predictions.
"The identification of very large numbers of single nucleotide polymorphisms (SNP) has enabled the use of genome-wide association studies (GWA) to detect alleles that are associated with risk for complex diseases" (Introduction, page 1-2).
Page Reference: Introduction, pages 1-2.
Example: This research primarily impacts the health domain by advancing genetic testing's precision in identifying disease risks. The practical application of these predictions can directly benefit healthcare systems in managing genetic diseases through personalized medicine, improving patient care, and aiding public health strategies for disease prevention.
2. Duration of Research Impact (RI)
Excerpts: The study presents long-term implications for how genetic risk is assessed. The deterministic equations provided will have lasting value in the design of future genomic studies and risk prediction methods.
"The predictions represent an upper bound of accuracy which may be achievable with improved effect estimation methods" (Conclusions, page 2).
Page Reference: Conclusions, page 2.
Example: The long-term impact is seen in the potential to shape future genetic and genomic research. The formulae could serve as a foundation for future studies that refine disease prediction techniques, leading to more accurate health interventions over the coming decades.
3. Stakeholder of Research Impact (RI)
Excerpts: The direct beneficiaries of this research include researchers in the field of genomics, clinicians using genetic risk predictions, and healthcare systems implementing personalized medicine.
"The formulae derived will help researchers determine an appropriate sample size to attain a certain accuracy when predicting genetic risk" (Abstract, page 1).
Page Reference: Abstract, page 1.
Example: Direct stakeholders include researchers developing genetic risk models and healthcare providers implementing these models to offer tailored treatment plans for patients at risk for complex diseases. Indirect stakeholders include patients and the general public who benefit from advancements in personalized medicine and genetic disease prevention strategies.
4. Depth and Breadth of Impact
Excerpts: The research has a deep impact on the field of genetics and genomics, particularly in improving methods for predicting genetic risks in complex diseases. Its methodology also has broad implications across healthcare, public health, and policy regarding genetic screening.
"Our predictive equations are responsive to all parameters that affect accuracy and they are independent of allele frequency and effect distributions" (Methodology, page 2).
Page Reference: Methodology, page 2.
Example: The research has a deep impact on genomics by introducing precise methods for risk prediction. Its broad impact lies in the potential application across public health, influencing policies on genetic testing and disease prevention strategies.
5. Scalability and Transferability
Excerpts: The methods developed for predicting genetic risk can be applied across various populations and diseases, indicating high scalability and transferability.
"We have derived simple deterministic formulae to predict the accuracy of predicted genetic risk from population or case-control studies using a genome-wide approach" (Methodology, page 1).
Page Reference: Methodology, page 1.
Example: The research offers scalability as its predictive models can be applied to larger, diverse populations. Its transferability lies in the potential to adapt these models for different complex diseases, making it useful across various genetic research contexts and medical fields.
6. Innovation and Disruption Potential
Excerpts: This research innovates by presenting deterministic equations for predicting genetic risk, advancing over traditional pedigree-based methods.
"Currently, prediction of risk for complex diseases is based mainly on pedigree analysis, but this approach yields predictions of risk that are of low precision" (Introduction, page 1).
Page Reference: Introduction, page 1.
Example: The innovation comes from improving precision in risk prediction for complex diseases using genome-wide data. This method could disrupt traditional genetic testing approaches by significantly enhancing the accuracy and reliability of disease risk predictions.
7. Sustainability and Ethical Considerations
Excerpts: Ethical considerations arise from the use of genetic data and the potential societal implications of predictive genetic testing.
"The predictions represent an upper bound of accuracy which may be achievable with improved effect estimation methods" (Conclusions, page 2).
Page Reference: Conclusions, page 2.
Example: The ethical implications of this research include ensuring privacy and fairness in the use of genetic information. The sustainability aspect is reflected in the potential for long-term improvements in public health through preventive measures informed by accurate genetic risk predictions.
8. Implementation and Usability
Excerpts: The research provides practical tools for improving the accuracy of genetic disease risk prediction, making it highly implementable in clinical and research settings.
"The formulae derived will help researchers determine an appropriate sample size to attain a certain accuracy when predicting genetic risk" (Abstract, page 1).
Page Reference: Abstract, page 1.
Example: Researchers and clinicians can easily implement these predictive equations to enhance the accuracy of genetic risk assessments in both research and healthcare.
9. Cross-disciplinary and Global Relevance
Excerpts: The research has relevance beyond the field of genetics, influencing healthcare, public policy, and disease prevention strategies on a global scale.
"Such predictions from genetic testing are relatively straightforward when a disease is caused by one or few genes, but more challenging when a disease is of complex inheritance" (Introduction, page 1).
Page Reference: Introduction, page 1.
Example: The study holds global relevance by providing insights that can influence public health policies and genetic research worldwide. Its cross-disciplinary influence extends to healthcare, genetics, bioethics, and public policy.
10. Resilience and Adaptability
Excerpts: The methods developed in this study are adaptable for use in varying genetic studies, making them resilient in the face of new genetic data and technological advancements.
"The formulae derived are robust to a wide range of parameters affecting accuracy, such as disease prevalence, heritability, and allele effects" (Results, page 4).
Page Reference: Results, page 4.
Example: The research is resilient as the formulas can be adapted to different diseases and populations. This adaptability ensures the continued relevance of the study's methods as genomic technologies evolve.
This detailed analysis captures the significant impacts of the study across multiple dimensions, highlighting its contribution to research, public health, and policy.